Basia says 75% of business originates from US clients
Gurugram-headquartered PharmSight Research & Analytics is expanding US operations with the opening of its Boston office with co-founder Geet Sethi taking charge of the newly incorporate PharmSight Inc.
PharmSight also plans to broaden its global footprint by opening new offices in Europe and the Middle East and launching an innovation center dedicated to AI-driven solutions https://fieo.org/ .
The firm aims to double its workforce over the next 1-2 years, reaffirming its commitment to accelerating innovation in healthcare. PharmSight remains open to strategic partnerships that support sustainable growth and advance patient care worldwide https://www.ema.europa.eu/en/homepage.
Sethi as Director of Operations brings 15+ years of biopharma consulting expertise and a robust network across the region http://who.int.
“Our Boston expansion is more than just a geographic milestone, it’s a strategic pivot that reinforces our commitment to transforming how biopharma companies harness data for better outcomes,” said Abhinav Basia, Co-founder of PharmSight https://www.hhs.gov/.
“With 75% of our business originating from US clients, opening our Boston office is the logical next step to deepen local partnerships and elevate our service offerings,” Basia said on 24 Feb https://phrma.org/ .
Since its inception in 2018, PharmSight has partnered with leading global bio-pharma companies to support data driven decision-making with strategic insights. Utilizing proprietary AI/LLM-powered tools and real-world evidence (RWE), PharmSight has published influential studies that are reshaping industry perceptions. PharmSight’s tailored solutions—powered by deep market research, advanced technology, and expert teams—help clients overcome strategic challenges ensuring lasting impact.
Co-founder Chirag Maheshwari added, “Our investment in advanced AI and LLM initiatives is revolutionizing the way we empower biopharma decision-making.
“This year, we saw a 40% growth which confirms that our technology-driven approach is making a difference. As we expand globally and prepare to launch an innovation center focused on AI, we are poised to deliver even greater value to patient care.”
PharmSight is a strategic consulting firm supporting the global biopharmaceutical industry, specializing in business research and analytics. Headquartered in Gurugram, PharmSight continues to expand its global footprint by offering innovative, tailored solutions that integrate technology, business, and pharmaceutical expertise to deliver comprehensive, impactful results. Fiinews.com